Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

CCO Oncology Podcast - Un pódcast de Clinical Care Options

Categorías:

In this podcast episode, listen to medical oncologists Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, discuss the rationale for using PARP inhibitors in combination with other therapies for prostate cancer.

Visit the podcast's native language site